News

"We are just at the beginning of a very exciting era," says Aerogen Director of R&D, Science and Emerging Technologies Ronan ...
New Delhi: Aerogen, an Ireland-based leader in acute-care aerosol drug delivery, has announced the opening of its India headquarters in the National Capital Territory (NCT) of Delhi. As per the ...
This device is dwarfed by a grain of rice, and can be injected into newborn babies with congenital heart diseases for temporary or long-term use with a regular syringe. About one in every 100 ...
The FENYX is valveless and able to self-prime 10x-40x faster than a syringe pump, helping OEMs eliminate unnecessary fluidic ...
Aerogen, the Ireland-based global leader in acute-care aerosol drug delivery, has announced the opening of its India headquarters in the National Capital Territory of Delhi. The new office was ...
Medicare Part D may cover insulin and certain medical supplies for injecting insulin, such as syringes. It may also cover disposable pumps and some oral diabetes medications. A person will need to ...
With over 55 million people in India affected by chronic obstructive pulmonary disease (COPD) and a rising burden of respiratory diseases, Aerogen’s vibrating mesh nebuliser technology is expected to ...
A legislative committee today heard testimony on a bill to limit needle and syringe exchange programs to one new needle or syringe for every used one brought in. But advocates said the proposal is a ...
The U.S. Food and Drug Administration (FDA) has approved a prefilled syringe format for Ani Pharmaceuticals’ purified Cortrophin Gel that’s expected to reduce the number of steps needed for ad ...
In a significant advancement for Nigeria’s healthcare sector, the Lagos State government has officially commissioned the O-Care Disposable Syringe Factory, Nigeria’s first facility dedicated ...
Another Continuous-Motion machine from Contexo is currently leaving the plant and will be in continuous use within a few days. Needle shields are urgently needed. Market demand is rising rapidly.